Literature DB >> 12643153

The epidemiology of neuropathic foot ulcers in individuals with diabetes.

Jay Sosenko1.   

Abstract

There is now substantial evidence that diabetic neuropathy is a major etiologic factor for diabetic foot ulcers. Epidemiologic data show a very strong association between foot ulcers and indicators of sensorimotor neuropathy. Additionally, a causal pathway (sensorimotor neuropathy, which leads to increased pressures at foot surfaces, which then leads to foot ulcers) has been postulated. Evidence suggests that other factors also contribute to foot ulcer risk through an interaction with neuropathy such as foot deformity, footwear, and body weight. There has been an effort to optimize modalities for screening diabetic patients for hypoesthesia in order to prevent foot ulcers; however, there have not been definitive prospective studies that have compared the effectiveness of available tests.

Entities:  

Mesh:

Year:  2002        PMID: 12643153     DOI: 10.1007/s11892-002-0116-0

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  27 in total

1.  Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial.

Authors:  H Pham; D G Armstrong; C Harvey; L B Harkless; J M Giurini; A Veves
Journal:  Diabetes Care       Date:  2000-05       Impact factor: 19.112

2.  Semmes-Weinstein monofilaments: a simple, effective and inexpensive screening device for identifying diabetic patients at risk of foot ulceration.

Authors:  S Kumar; D J Fernando; A Veves; E A Knowles; M J Young; A J Boulton
Journal:  Diabetes Res Clin Pract       Date:  1991-08       Impact factor: 5.602

3.  Neurofunctional testing for the detection of diabetic peripheral neuropathy.

Authors:  J M Sosenko; M T Gadia; N Natori; D R Ayyar; L B Ramos; J S Skyler
Journal:  Arch Intern Med       Date:  1987-10

4.  Incidence, outcomes, and cost of foot ulcers in patients with diabetes.

Authors:  S D Ramsey; K Newton; D Blough; D K McCulloch; N Sandhu; G E Reiber; E H Wagner
Journal:  Diabetes Care       Date:  1999-03       Impact factor: 19.112

5.  A prospective study of predictors for foot ulceration in type 2 diabetes.

Authors:  T Kästenbauer; S Sauseng; G Sokol; M Auinger; K Irsigler
Journal:  J Am Podiatr Med Assoc       Date:  2001 Jul-Aug

6.  Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings.

Authors:  G E Reiber; L Vileikyte; E J Boyko; M del Aguila; D G Smith; L A Lavery; A J Boulton
Journal:  Diabetes Care       Date:  1999-01       Impact factor: 19.112

7.  Practical criteria for screening patients at high risk for diabetic foot ulceration.

Authors:  L A Lavery; D G Armstrong; S A Vela; T L Quebedeaux; J G Fleischli
Journal:  Arch Intern Med       Date:  1998-01-26

8.  The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort.

Authors:  C A Abbott; A L Carrington; H Ashe; S Bath; L C Every; J Griffiths; A W Hann; A Hussein; N Jackson; K E Johnson; C H Ryder; R Torkington; E R E Van Ross; A M Whalley; P Widdows; S Williamson; A J M Boulton
Journal:  Diabet Med       Date:  2002-05       Impact factor: 4.359

9.  Body mass is a poor predictor of peak plantar pressure in diabetic men.

Authors:  P R Cavanagh; D S Sims; L J Sanders
Journal:  Diabetes Care       Date:  1991-08       Impact factor: 19.112

10.  Identifying diabetic patients at high risk for lower-extremity amputation in a primary health care setting. A prospective evaluation of simple screening criteria.

Authors:  S J Rith-Najarian; T Stolusky; D M Gohdes
Journal:  Diabetes Care       Date:  1992-10       Impact factor: 19.112

View more
  1 in total

1.  Comparison of shoe-length fit between people with and without diabetic peripheral neuropathy: a case-control study.

Authors:  Alistair D McInnes; Farina Hashmi; Lisa J Farndon; Amanda Church; Maria Haley; Debora M Sanger; Wesley Vernon
Journal:  J Foot Ankle Res       Date:  2012-04-16       Impact factor: 2.303

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.